TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Indonesia allows emergency use of Sinovac vaccine

  • Ardila Syakriah
    Ardila Syakriah

    The Jakarta Post

PREMIUM
Jakarta   /   Mon, January 11, 2021   /  09:32 pm
The Jakarta Post Image
Workers unload containers carrying the Sinovac vaccine for COVID-19 under National Police security at Soekarno-Hatta International Airport in Tangerang, Banten, on Dec. 31, 2020. As many as 1.8 million doses of Chinese firm Sinovac Biotech's COVID-19 vaccine, CoronaVac, arrived in Indonesia as the government eyes to roll out vaccination for medical workers in January.(Antara/Muhammad Iqbal)

The Food and Drug Monitoring Agency (BPOM) has issued an emergency use authorization for Chinese firm Sinovac Biotech's COVID-19 vaccine after interim results of its late-stage trials in the country showed an efficacy rate of 65.3 percent. This makes Indonesia the first country outside China to issue the emergency approval for the vaccine named CoronaVac, with President Joko "Jokowi" Widodo scheduled to receive the first shot on Jan. 13. Around 1.3 million health workers are expected to follow suit in the first few months of the free vaccination program. The efficacy rate was derived from interim results after three months of monitoring in a six-month trial in Bandung, West Java, BPOM head Penny K. Lukito said on Monday. The figure is lower than rates of 91.25 percent and 78 percent, respectively, reported by Turkish and Brazilian authorities, which Penny said had als...